Showing results (191-200 of 227) with videos related to

Sort By:
Pageof 23
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2024
Extraaxial Poorly Differentiated Chordoma: Clinicopathologic and Molecular Genetic CharacterizationWilliam J Sande, Andrew L Folpe, Paige O'Connor, et al.
Nature Medicine|September 13, 2022
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphomaNicholas J Haradhvala, Mark B Leick, Katie Maurer, et al.
Blood|June 18, 2013
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanomaGerald P Linette, Edward A Stadtmauer, Marcela V Maus, et al.
Lancet (London, England)|December 14, 2020
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studiesReuben Benjamin, Charlotte Graham, Deborah Yallop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2020
Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and ToxicityCaron A Jacobson, Bradley D Hunter, Robert Redd, et al.
Nature Neuroscience|May 30, 2024
Nf1 mutation disrupts activity-dependent oligodendroglial plasticity and motor learning in miceYuan Pan, Jared D Hysinger, Belgin Yalçın, et al.
Cell|April 23, 2024
Integrative spatial analysis reveals a multi-layered organization of glioblastomaAlissa C Greenwald, Noam Galili Darnell, Rouven Hoefflin, et al.
Blood|February 15, 2022
Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trialMatthew J Frigault, Jorg Dietrich, Kathleen Gallagher, et al.
Blood Advances|March 29, 2022
Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemiaSaar Gill, Vanessa Vides, Noelle V Frey, et al.
Blood Advances|February 10, 2025
Single-cell dynamics of breakthrough toxicities after anakinra prophylaxis for axicabtagene ciloleucel in lymphomaMatthew J Frigault, Ning Yao, Trisha R Berger, et al.
Pageof 23